Evidence map›Paper›PMID 24344267›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Effective functional maturation of invariant natural killer T cells is constrained by negative selection and T-cell antigen receptor affinity.

Romain Bedel, Richard Berry, Thierry Mallevaey, Jennifer L Matsuda, Jingjing Zhang, Dale I Godfrey, Jamie Rossjohn, John W Kappler, Philippa Marrack, Laurent Gapin

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Clonally expanded memory CD8Nature aging · 2023
    Article
  4. Review
  5. Markers and makers of NKT17 cells.Experimental & molecular medicine · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Development of invariant natural killer T cells.Current opinion in immunology · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Romain BedelIntegrated Department of Immunology, National Jewish Health and University of Colorado School of Medicine, Denver, CO 80206.
Richard Berry
Thierry Mallevaey
Jennifer L Matsuda
Jingjing Zhang
Dale I Godfrey
Jamie Rossjohn
John W Kappler
Philippa Marrack
Laurent Gapin
National Jewish Health · USCardiff University · GBMonash University · AUUniversity of Colorado Denver · USUniversity of Melbourne · AU

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2011
$11.7M
CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
iNKT Cell Recognition of Endogenous Lipid AntigensR01AI092108 · NIAID · UNIVERSITY OF COLORADO DENVER · PI GAPIN, LAURENT · 2011 to 2014
$1.5M
CHARACTERISTICS OF T-CELL RECEPTORSR37AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1992 to 2001
$522k
Characteristics of T Cell ReceptorsR56AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2012 to 2012
$410k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA046934NCI NIH HHS P30CA046934NIAID NIH HHS AI092108NIAID NIH HHS AI18785NIAID NIH HHS AI22295NIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI018785NIAID NIH HHS R01 AI092108NIAID NIH HHS R37 AI018785NIAID NIH HHS R56 AI018785NIGMS NIH HHS T32 GM008497
6 · The paper itself

Abstract

The self-reactivity of their T-cell antigen receptor (TCR) is thought to contribute to the development of immune regulatory cells, such as invariant NK T cells (iNKT). In the mouse, iNKT cells express TCRs composed of a unique Vα14-Jα18 rearrangement and recognize lipid antigens presented by CD1d molecules. We created mice expressing a transgenic TCR-β chain that confers high affinity for self-lipid/CD1d complexes when randomly paired with the mouse iNKT Vα14-Jα18 rearrangement to study their development. We show that although iNKT cells undergo agonist selection, their development is also shaped by negative selection in vivo. In addition, iNKT cells that avoid negative selection in these mice express natural sequence variants of the canonical TCR-α and decreased affinity for self/CD1d. However, limiting the affinity of the iNKT TCRs for "self" leads to inefficient Egr2 induction, poor expression of the iNKT lineage-specific zinc-finger transcription factor PLZF, inadequate proliferation of iNKT cell precursors, defects in trafficking, and impaired effector functions. Thus, proper development of fully functional iNKT cells is constrained by a limited range of TCR affinity that plays a key role in triggering the iNKT cell-differentiation pathway. These results provide a direct link between the affinity of the TCR expressed by T-cell precursors for self-antigens and the proper development of a unique population of lymphocytes essential to immune responses.

Indexed as

AnimalsAntigens, CD1dCell DifferentiationEarly Growth Response Protein 2Flow CytometryGene Expression RegulationImmune SystemLymph NodesMiceMice, Inbred C57BLMice, TransgenicMutationNatural Killer T-CellsPromoter Regions, GeneticReceptors, Antigen, T-Cell, alpha-betaRetroviridaeAntigens, CD1dEarly Growth Response Protein 2Egr2 protein, mouseReceptors, Antigen, T-Cell, alpha-betadeletionthymus

Identifiers

PMID24344267
PMCPMC3890789
OpenAlexW2003559438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.